https://femifajimi.org/2025/11/27/writing-lay-summaries-what-i-didnt-expect-to-learn-as-a-regulatory-writer/2025-11-27T12:09:16+00:00monthlyhttps://femifajimi.org/portfolio/2025-11-27T11:17:25+00:00weekly0.6https://femifajimi.org/2025/09/10/from-raw-tfls-to-regulator-ready-narratives-a-medical-writers-walkthrough-antifungal-case-study/2025-09-10T13:37:06+00:00monthlyhttps://femifajimi.org/2025/08/08/writing-briefing-documents-for-scientific-advice-meetings-a-step-by-step-guide-using-azidomyxin/2025-08-08T14:54:09+00:00monthlyhttps://femifajimi.org/contact/2025-08-01T13:24:13+00:00weekly0.6https://femifajimi.org/2025/07/26/clinical-overviews-and-clinical-summaries-in-regulatory-submissions-a-regulatory-writing-walkthrough-with-oncometherin/2025-07-26T13:00:37+00:00monthlyhttps://femifajimi.org/2025/07/16/understanding-development-safety-update-reports-dsurs-a-dermalexiin-case-study/2025-07-16T11:45:37+00:00monthlyhttps://femifajimi.org/2025/07/02/understanding-pre-clinical-modules-of-the-ctd-a-dermalexiin-case-study/2025-07-15T09:30:05+00:00monthlyhttps://femifajimi.org/2025/06/23/the-investigational-medicinal-product-dossier-impd-an-overview-from-a-developing-medical-writer/2025-06-23T07:53:06+00:00monthlyhttps://femifajimi.org/2025/06/13/writing-safety-updates-in-regulatory-medical-writing-an-overview-of-rmps-dsurs-paders-and-pbrers-from-a-developing-writers-perspective/2025-06-13T07:39:57+00:00monthlyhttps://femifajimi.org/2025/06/09/medical-writing-in-oncology-what-makes-it-unique/2025-06-09T08:42:02+00:00monthlyhttps://femifajimi.org/2025/06/02/understanding-the-paediatric-investigation-plan-pip-how-it-differs-from-a-clinical-trial-protocol/2025-06-02T22:32:53+00:00monthlyhttps://femifajimi.org/2025/05/29/understanding-the-ctd-where-clinical-data-meets-regulatory-writing/2025-05-29T09:03:59+00:00monthlyhttps://femifajimi.org/2025/05/22/from-numbers-to-narrative-learning-to-understand-clinical-data-as-a-medical-writer/2025-05-22T12:37:06+00:00monthlyhttps://femifajimi.org/2025/05/15/writing-the-participant-information-sheet-a-practical-introduction/2025-05-15T10:41:15+00:00monthlyhttps://femifajimi.org/about-me/https://femifajimi.org/wp-content/uploads/2025/04/img_1115-removebg-preview.pngIMG_1115-removebg-previewhttps://femifajimi.org/wp-content/uploads/2025/04/img_1115.jpgIMG_1115https://femifajimi.org/wp-content/uploads/2025/04/img_1116.jpgIMG_11162025-05-14T12:45:54+00:00weekly0.6https://femifajimi.org/2025/05/08/understanding-protocol-amendments-a-beginners-perspective/2025-05-14T04:36:58+00:00monthlyhttps://femifajimi.org/2025/05/14/writing-for-ethics-committee-submissions-practical-insights-from-a-developing-writer/2025-05-14T04:35:19+00:00monthlyhttps://femifajimi.org/2025/05/05/understanding-the-ich-guidelines-e3-e6-and-e8-from-a-medical-writers-perspective/2025-05-05T11:44:26+00:00monthlyhttps://femifajimi.org/2025/05/01/basic-results-and-trial-disclosure-reporting-transparency-in-action/2025-04-30T23:44:51+00:00monthlyhttps://femifajimi.org/2025/04/29/lay-summaries-in-clinical-trials-a-beginners-perspective-on-making-research-understandable/2025-04-29T08:42:26+00:00monthlyhttps://femifajimi.org/2025/04/28/clinical-trial-protocols-and-clinical-study-reports-csrs-a-beginners-perspective/2025-04-28T17:23:58+00:00monthlyhttps://femifajimi.org/2025/04/26/investigators-brochure-and-updates-a-beginners-guide/2025-04-27T19:26:49+00:00monthlyhttps://femifajimi.org/2025/04/21/starting-somewhere/2025-04-25T00:13:16+00:00monthlyhttps://femifajimi.org/2025/04/25/writing-patient-narratives-in-clinical-trials-a-beginners-guide/2025-04-25T00:04:41+00:00monthlyhttps://femifajimi.org/2025/04/24/understanding-informed-consent-forms-icf/2025-04-24T14:40:47+00:00monthlyhttps://femifajimi.org/blog/2025-04-20T18:54:15+00:00weekly0.6https://femifajimi.orgdaily1.02025-11-27T12:09:16+00:00